Background:
Symptoms and functional impairments have historically represented the primary targets of hypertrophic cardiomyopathy (HCM) management. Obesity has been shown to be associated with worse symptoms and clinical outcomes in HCM, but the extent to which obesity influences patient-reported health status across...
J. Ostrominski, B. Claggett, A. Axelsson Raja et al.· Circulation· 0 citations
BACKGROUND
Atrial fibrillation (AF) is the most common arrhythmia in dilated cardiomyopathy (DCM) and is associated with adverse outcomes. However, the genetic determinants of AF risk and its prognostic significance across genotyped DCM subtypes remain unknown.
METHODS
In this observational cohort study, we analyzed...
I. Balakrishnan, A. Heymans, B. Claggett et al.· Circulation: Heart Failure· 0 citations
Unsupervised and supervised machine learning approaches distinguished HCM from dilated cardiomyopathy and accurately predicted genotype status in early-stage HCM from cell type-resolved transcriptional profiles, revealing widespread genotype-driven remodeling.
E. Adami, Yuri Kim, Sean L. Zheng et al.· Science Translational Medici...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.